This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.3390/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q94593648
rdf:type
wikibase:Item
schema:description
scientific article published on 10 May 2020 wetenschappelijk artikel 2020 թվականի մայիսի 10-ին հրատարակված գիտական հոդված наукова стаття, опублікована 10 травня 2020 artículu científicu espublizáu en mayu de 2020
p:P577
wds:Q94593648-726EF3B0-0071-4C61-834A-8BA08D46AA9D
wdt:P577
2020-05-10T00:00:00Z
p:P2093
wds:Q94593648-F9DFEAAB-6E03-44D3-9B83-5858FBF29F78 wds:Q94593648-0C88EE1D-3EC2-4324-879C-16309D6A2A85 wds:Q94593648-1063EFF8-0AC8-4DE1-AD65-F8CAF4333FE9
wdt:P2093
Elvira Favoino Giacomo Catacchio Marcella Prete
rdfs:label
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
skos:prefLabel
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
schema:name
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
p:P50
wds:Q94593648-AA54873A-58F9-4710-A301-823EC9F4F338 wds:Q94593648-62342405-6D3C-4228-B6BE-8AF1611B6065
wdt:P50
wd:Q46257032 wd:Q56678833
p:P1476
wds:Q94593648-719A35AF-F032-4704-822A-D6E2DE1BD34E
wdt:P1476
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
p:P31
wds:Q94593648-f50f7253-638c-4f6b-9415-0a7a9615543f wds:Q94593648-BAEEA556-A7BF-4FFC-BBFC-90185D150CD8
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q94593648-C0B9BABB-13A7-4295-BAE1-D774B567ACBA
wdt:P921
wd:Q82069695
p:P698
wds:Q94593648-183A68A4-B6DF-4905-8CE3-0580EEB1289A
wdtn:P698
n10:32397684
wdt:P698
32397684
p:P1433
wds:Q94593648-D1061591-A4EE-4690-9F5B-47B34FDC2F5A
wdt:P1433
wd:Q3153277
p:P433
wds:Q94593648-43A60E4D-4FC5-453E-BA78-FE3703BBE8D3
p:P478
wds:Q94593648-29A288B2-7026-4AF3-880B-EB00BA40BD2B
wdt:P433
9
wdt:P478
21
p:P356
wds:Q94593648-8D93109C-8982-4EED-B3A0-2D90A0C6376F
wdtn:P356
n9:IJMS21093377
wdt:P356
10.3390/IJMS21093377
p:P275
wds:Q94593648-ee3fbc05-e426-43f2-b141-5929757c61e6
p:P6216
wds:Q94593648-d3995b9e-b6b5-4c45-9580-3f2fb6db93cc
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P8299
wds:Q94593648-906C6059-8D11-4099-8618-901F4DF5B143
wdt:P8299
218619031
p:P6179
wds:Q94593648-7F4CC138-8F6D-4BD6-A382-3EB1EB443F44
wdt:P6179
1127533220
p:P932
wds:Q94593648-DD26B369-A52C-489E-ADD2-97AB0C381023
wdt:P932
7247005
p:P8150
wds:Q94593648-7bc07ce1-050c-46bd-b8a1-479b310fa3f6
wdt:P8150
covidwho-209969